India has the highest number of TB victims, with an estimated incidence of 2.2 million cases out of a global incidence of 8.7 million cases (WHO 2011). The problem of TB in India is exacerbated by interruption in treatment adherence, and this has led to evolution of several mutant strains that are drug resistant. Treatment for TB is a significantly long process, and adherence to treatment can sometimes be compromised.
Grand Challenges in TB Control (GC-TBC) is an initiative to encourage and nurture innovation that will better address the TB treatment adherence scene, a major challenge in the field of TB disease management and control. IKP Knowledge Park (IKP), the United States Agency for International Development (USAID), and the Bill & Melinda Gates Foundation (Foundation) are working together to identify, fund, and nurture technology driven solutions that will assist TB control.
The GC-TBC initiative aims to address the global health challenge of TB Control by encouraging entrepreneurship through technology innovation, and enabling the integration of such innovations with the public and private health care systems. GC-TBC is established as a unique grant program to fund out-of-the-box innovations in TB control. We will not only provide grant funds but also work with grantees for two years to help establish the proof-of-concept and bring to grantees the deep collective experience of global mentors, resources and network.
|Name||Company Logo||Website Url|